US › Healthcare

Sonoma Pharmaceuticals Inc (SNOA)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.12-2.61%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$6.4M

Revenue YoY

+59.6%

Net profit

$-330,000

EPS

$0.02

Net margin

-5.2%

Key statistics

Market cap

$5.7M

Forward P/E

46.1

P/B

0.91

Book value

$1.38

EPS (TTM)

$-1.22

52-week high

$4.25

52-week low

$0.85

50-day MA

$1.28

200-day MA

$1.86

Beta

1.30

Analyst view

with an average price target of $12.00.

Shareholding

Insiders

0.42%

Institutions

2.31%

Largest institutional holders

Fund	Stake
Renaissance Technologies Corp	0.85%
Geode Capital Management, LLC	0.56%
Vanguard Capital Management, LLC	0.39%
Mckinley Carter Wealth Services Inc	0.23%
UBS Group AG	0.16%
Global Retirement Partners, LLC.	0.05%
Morgan Stanley - Brokerage Accounts	0.04%
Advisor Group Holdings, Inc.	0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sonoma Pharmaceuticals Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.